In a lady with history of bih of a previous child with neural tube defect, amount of folic acid to be given in microgram as secondary prophylaxis before next conception is:
First, I need to recall the core concept here. Neural tube defects are preventable with folic acid supplementation. The key point is the dosage required for secondary prevention, which is different from the general population's primary prevention. For women with a history of NTD in a previous child, the recommended dose is higher than the standard 400 mcg. I remember that the standard recommendation for women with a previous NTD is 4 mg (4000 mcg) daily, starting at least one month before conception and continuing through the first trimester.
Now, the options aren't listed, but common distractors might include lower doses like 400 mcg, 5 mg, or maybe 1 mg. The correct answer is 4 mg. Let me verify that. Yes, according to guidelines from organizations like the CDC and the American College of Obstetricians and Gynecologists, women with a history of NTD should take 4 mg of folic acid daily.
For the incorrect options: 400 mcg is the standard for general population's primary prevention. 5 mg might be a distractor, but the correct dose is 4 mg. 1 mg is sometimes used in other conditions like folate deficiency anemia but not for NTD prevention.
The clinical pearl here is to remember the higher dose for secondary prevention. A mnemonic could be "4 mg for 4 previous NTD." Also, it's important to start the supplementation before conception, not just after. The student should never forget that the dosage is significantly higher than the standard recommendation.
**Core Concept**
Neural tube defects (NTDs) are largely preventable with adequate folic acid supplementation. For women with a prior child with NTD, secondary prevention requires a higher dose of folic acid (4 mg/day) compared to the general population (400 mcg/day) to reduce recurrence risk. This is due to the role of folate in DNA synthesis and neural tube closure.
**Why the Correct Answer is Right**
The correct dose is **4 mg (4000 mcg)** of folic acid daily, initiated at least 1 month before conception and continued through the first trimester. This higher dose compensates for potential folate metabolism defects (e.g., MTHFR gene polymorphisms) and ensures sufficient folate levels to prevent neural tube closure defects. Clinical trials show this reduces recurrence risk by 70–90%.
**Why Each Wrong Option is Incorrect**
**Option A:** 400 mcg is the standard primary prevention dose for the general population but insufficient for women with prior NTD.
**Option B:** 5 mg exceeds the recommended dose without proven additional benefit and may mask vitamin B12 deficiency.
**Option C:** 1 mg is insufficient to achieve the plasma folate concentrations needed for NTD prevention in high-risk cases.
**Clinical Pearl / High-Yield Fact**
Remember: **4 mg for 4 NTDs**—4 mg/day is the high-dose folic acid regimen for women with a history of 1 or more NTD-affected pregnancies